Yes, the funding question was answered a little different and glad he said they have a strategy and plan to stop the dilutive financing. I understood the meeting next week is when the funding strategy / plan will be discussed. $12k was less than I expected, but likely misleading and is not the complete cost associated with the study (i.e. CRO expenses are likely much more than that alone).